Literature DB >> 10615250

Dominant distribution of mitochondrial DNA from recipient oocytes in bovine embryos and offspring after nuclear transfer.

K Takeda1, S Takahashi, A Onishi, Y Goto, A Miyazawa, H Imai.   

Abstract

In the process of nuclear transfer, heteroplasmic sources of mitochondrial DNA from a donor cell and a recipient oocyte are mixed in the cytoplasm of the reconstituted embryo. The distribution of mitochondrial DNA heteroplasmy in nuclear transfer bovine embryos and resultant offspring was investigated by measuring polymorphism in the displacement loop region of mitochondrial DNA using PCR-mediated single-strand conformation polymorphism. Most offspring (20 of 21 calves) from recipient oocytes of undefined mitochondrial DNA genotypes showed different genotypes from the mitochondrial DNA of donor cells. The single calf that was an exception showed heteroplasmy, including the donor mitochondrial DNA genotype. Six cloned calves were produced from oocytes of a defined mitochondrial DNA genotype. All of these clonal members and various tissues showed only the mitochondrial DNA genotype derived from the oocyte. The mitochondrial DNA from donor cells appeared to be eliminated during early embryonic development; it gradually decreased at the early cleavage stages and was hardly detectable by the blastocyst stage. These results indicate that the genotype of mitochondrial DNA from recipient oocytes may become the dominant category of mitochondrial DNA in calves resulting from nuclear transfer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10615250     DOI: 10.1530/jrf.0.1160253

Source DB:  PubMed          Journal:  J Reprod Fertil        ISSN: 0022-4251


  10 in total

1.  Replicative advantage and tissue-specific segregation of RR mitochondrial DNA between C57BL/6 and RR heteroplasmic mice.

Authors:  K Takeda; S Takahashi; A Onishi; H Hanada; H Imai
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  Complete replacement of the mitochondrial genotype in a Bos indicus calf reconstructed by nuclear transfer to a Bos taurus oocyte.

Authors:  F V Meirelles; V Bordignon; Y Watanabe; M Watanabe; A Dayan; R B Lôbo; J M Garcia; L C Smith
Journal:  Genetics       Date:  2001-05       Impact factor: 4.562

3.  Paternal mitochondrial DNA transmission during nonhuman primate nuclear transfer.

Authors:  Justin C St John; Gerald Schatten
Journal:  Genetics       Date:  2004-06       Impact factor: 4.562

4.  Coexistence of Bos taurus and B. indicus mitochondrial DNAs in nuclear transfer-derived somatic cattle clones.

Authors:  Ralf Steinborn; Pamela Schinogl; David N Wells; Andreas Bergthaler; Mathias Müller; Gottfried Brem
Journal:  Genetics       Date:  2002-10       Impact factor: 4.562

Review 5.  Interspecies somatic cell nuclear transfer and preliminary data for horse-cow/mouse iSCNT.

Authors:  R Tayfur Tecirlioglu; Jitong Guo; Alan O Trounson
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

6.  Human therapeutic cloning (NTSC): applying research from mammalian reproductive cloning.

Authors:  Andrew J French; Samuel H Wood; Alan O Trounson
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

Review 7.  Factors affecting the development of somatic cell nuclear transfer embryos in Cattle.

Authors:  Satoshi Akagi; Kazutsugu Matsukawa; Seiya Takahashi
Journal:  J Reprod Dev       Date:  2014       Impact factor: 2.214

Review 8.  Strategies to Improve the Efficiency of Somatic Cell Nuclear Transfer.

Authors:  Kanokwan Srirattana; Masahiro Kaneda; Rangsun Parnpai
Journal:  Int J Mol Sci       Date:  2022-02-10       Impact factor: 5.923

9.  Autologous somatic cell nuclear transfer in pigs using recipient oocytes and donor cells from the same animal.

Authors:  Eunsong Lee; Kilyoung Song
Journal:  J Vet Sci       Date:  2007-12       Impact factor: 1.672

10.  Inclusion of genetically identical animals to a numerator relationship matrix and modification of its inverse.

Authors:  Takuro Oikawa; Kazuhiro Yasuda
Journal:  Genet Sel Evol       Date:  2009-03-03       Impact factor: 4.297

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.